November 26, 2025

McDermott Will & Schulte advises Compeer Financial in its $300 million offering of preferred stock

November 26, 2025

McDermott Will & Schulte advises Tarrytown Expocare Pharmacy and Sheridan Capital Partners in sale to Carlyle

November 26, 2025

McDermott Will & Schulte advises Chesneau-Serret Group and Weinberg Capital Partners on the acquisition of LGB

26. November 2025

McDermott berät Merck bei strategischer Partnerschaft mit Valo Health

November 25, 2025

Sarah Kitchell named to Boston Magazine’s Top Lawyers list in healthcare law

November 25, 2025

McDermott Will & Schulte ranked in GRR 30 and recognized for high-profile, complex restructurings

9. September 2025

Beziehungen im Job: Wann Beziehungen am Arbeitsplatz erlaubt sind

November 21, 2025

McDermott Will & Schulte advises major banks on Northern Trust Corporation’s $1.25 billion notes offering

November 20, 2025

McDermott Will & Schulte once again recognized in Global Investigations Review’s GIR 100 2025

15. November 2025

Continuation Funds: Transparenz reduziert Risiken

November 19, 2025

McDermott Will & Schulte recognized in International Tax Review’s 2026 World Tax Guide

November 18, 2025

McDermott Will & Schulte represents Deep Track Capital in its investment in Hemab Therapeutics

November 2025

The CJEU contradicts the traditional approach of personal data protection authorities

November 12, 2025

McDermott Will & Schulte ranked among Top 50 leading firms in Germany by the JUVE Handbook 2025/2026

November 10, 2025

McDermott Will & Schulte advised Ardian on the sale of its stake in Eloquant to Harris

November 7, 2025

Bridging the expectation gap: Finance leaders debunk outdated career myths

November 7, 2025

McDermott Will & Schulte represents GreenWood Investors in agreement with Jack in the Box

November 7, 2025

McDermott Will & Schulte advised H.A.C. Pharma on its acquisition from Roche of the worldwide (excluding the US) rights to the drug ESBRIET®